List view / Grid view

Maarten Meulenbelt (Sidley Austin LLP)

 

article

2022 spells change for EU pharmaceutical legislation

With almost every aspect of pharmaceutical regulation currently under review…

24 June 2022 | By

With almost every aspect of pharmaceutical regulation currently under review across Europe and the proposal for changes expected in December 2022, in this article, Maarten Meulenbelt, Partner at Sidley Austin LLP, discusses with European Pharmaceutical Review some of the more controversial amendments under consideration and emphasises why industry participation is…